首页 > 最新文献

The Lancet Regional Health: Western Pacific最新文献

英文 中文
A population-based study of traumatic brain injury incidence and mechanisms in New Zealand: 2021–2022 compared with 2010–2011 新西兰创伤性脑损伤发生率和机制的基于人群的研究:2021-2022与2010-2011的比较
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-22 DOI: 10.1016/j.lanwpc.2026.101797
Kelly Jones , Alice Theadom , Nicola Starkey , Irene Zeng , Shanthi Ameratunga , Suzanne Barker-Collo , Laura Wilkinson-Meyers , Braden Te Ao , Nathan Henry , Luke A. McClean , Jennifer Chua , Leah Haumaha , Michael Kahan , Grant Christey , Natalie Hardaker , Amy Jones , Anthony Dowell , Valery Feigin

Background

Monitoring traumatic brain injury (TBI) incidence and epidemiological patterns is important for evidence-based strategic planning, policy, prevention, and resource allocation. We revisited population-based estimates and examined patterns of TBI incidence (all ages, severities) in 2021–2022 compared with 2010–2011 in New Zealand (NZ).

Methods

Examining an urban (Hamilton) and rural (Waikato District) region in NZ (May 2021–April 2022, unintentionally following the start of the COVID-19 pandemic), we calculated crude annual age-, sex-, ethnic-, urban/rural area- and mechanism-specific TBI incidence per 100,000 person-years with 95% Confidence Intervals (CI). Poisson regression was used to derive adjusted Risk Ratios (aRRs) to compare age-standardised rates between sex, ethnicity, and area groups. Direct standardisation was used to age-standardise rates to the world population. We calculated Incidence Rate Ratios (IRRs) with 95% CI to compare 2021–2022 with 2010–2011 age-standardised rates.

Findings

Total TBI incidence per 100,000 person-years was 852 cases (95% CI 816–890), including 791 cases (756–828) of mild TBI, and 61 cases (52–72) of moderate to severe TBI. TBI affected males more than females (IRR 1.31, 95% CI 1.29–1.33), and urban more than rural residents (IRR 1.57, 1.43–1.73). Most TBI (61%) occurred in people aged 15–64 years and were due to falls (48%). European and Asian peoples had lower risk of TBI than Māori (aRRs 0.68, 0.31 respectively). Compared to 2010–2011, total TBI incidence and rates among Māori were stable; TBI incidence was greater among females, urban residents, and adults aged ≥34 years; and TBI due to falls significantly increased (IRR 1.20, 95% CI 1.03–1.40).

Interpretation

Noting increased risks for underestimation due to COVID-19, findings suggest overall TBI incidence rate in NZ was similar in 2021–2022 to 2010–2011, while highlighting changes in TBI distribution. Age-, sex-, area-, ethnic-, and mechanism-specific distributions should be considered when revisiting prevention strategies to reduce TBI incidence.

Funding

Health Research Council of New Zealand of NZ.
背景:监测创伤性脑损伤(TBI)发病率和流行病学模式对循证战略规划、政策、预防和资源分配具有重要意义。我们重新评估了基于人群的估计,并检查了2021-2022年与2010-2011年新西兰TBI发病率(所有年龄、严重程度)的模式。方法研究了新西兰的城市(汉密尔顿)和农村(怀卡托区)地区(2021年5月至2022年4月,在COVID-19大流行开始后无意中),我们计算了每10万人年的年龄、性别、种族、城市/农村地区和机制特异性TBI发病率,置信区间为95% (CI)。泊松回归用于得出校正风险比(aRRs),以比较性别、种族和地区群体之间的年龄标准化发病率。直接标准化被用来对世界人口的年龄比率进行标准化。我们计算了2021-2022年与2010-2011年年龄标准化发病率的95% CI发生率比(IRRs)。发现每10万人年总TBI发病率为852例(95% CI 816-890),其中791例(756-828)为轻度TBI, 61例(52-72)为中度至重度TBI。脑外伤对男性的影响大于女性(IRR 1.31, 95% CI 1.29-1.33),对城市居民的影响大于农村居民(IRR 1.57, 1.43-1.73)。大多数TBI(61%)发生在15-64岁的人群中,由跌倒引起(48%)。欧洲和亚洲人群的TBI风险低于Māori (aRRs分别为0.68和0.31)。与2010-2011年相比,Māori的总TBI发病率和发病率保持稳定;女性、城市居民和年龄≥34岁的成年人的TBI发病率较高;跌落引起的TBI显著增加(IRR 1.20, 95% CI 1.03-1.40)。由于COVID-19导致低估的风险增加,研究结果表明,2021-2022年新西兰的总体TBI发病率与2010-2011年相似,同时突出了TBI分布的变化。在重新制定预防策略以减少TBI发生率时,应考虑年龄、性别、地区、种族和机制特异性分布。资助新西兰卫生研究理事会。
{"title":"A population-based study of traumatic brain injury incidence and mechanisms in New Zealand: 2021–2022 compared with 2010–2011","authors":"Kelly Jones ,&nbsp;Alice Theadom ,&nbsp;Nicola Starkey ,&nbsp;Irene Zeng ,&nbsp;Shanthi Ameratunga ,&nbsp;Suzanne Barker-Collo ,&nbsp;Laura Wilkinson-Meyers ,&nbsp;Braden Te Ao ,&nbsp;Nathan Henry ,&nbsp;Luke A. McClean ,&nbsp;Jennifer Chua ,&nbsp;Leah Haumaha ,&nbsp;Michael Kahan ,&nbsp;Grant Christey ,&nbsp;Natalie Hardaker ,&nbsp;Amy Jones ,&nbsp;Anthony Dowell ,&nbsp;Valery Feigin","doi":"10.1016/j.lanwpc.2026.101797","DOIUrl":"10.1016/j.lanwpc.2026.101797","url":null,"abstract":"<div><h3>Background</h3><div>Monitoring traumatic brain injury (TBI) incidence and epidemiological patterns is important for evidence-based strategic planning, policy, prevention, and resource allocation. We revisited population-based estimates and examined patterns of TBI incidence (all ages, severities) in 2021–2022 compared with 2010–2011 in New Zealand (NZ).</div></div><div><h3>Methods</h3><div>Examining an urban (Hamilton) and rural (Waikato District) region in NZ (May 2021–April 2022, unintentionally following the start of the COVID-19 pandemic), we calculated crude annual age-, sex-, ethnic-, urban/rural area- and mechanism-specific TBI incidence per 100,000 person-years with 95% Confidence Intervals (CI). Poisson regression was used to derive adjusted Risk Ratios (aRRs) to compare age-standardised rates between sex, ethnicity, and area groups. Direct standardisation was used to age-standardise rates to the world population. We calculated Incidence Rate Ratios (IRRs) with 95% CI to compare 2021–2022 with 2010–2011 age-standardised rates.</div></div><div><h3>Findings</h3><div>Total TBI incidence per 100,000 person-years was 852 cases (95% CI 816–890), including 791 cases (756–828) of mild TBI, and 61 cases (52–72) of moderate to severe TBI. TBI affected males more than females (IRR 1.31, 95% CI 1.29–1.33), and urban more than rural residents (IRR 1.57, 1.43–1.73). Most TBI (61%) occurred in people aged 15–64 years and were due to falls (48%). European and Asian peoples had lower risk of TBI than Māori (aRRs 0.68, 0.31 respectively). Compared to 2010–2011, total TBI incidence and rates among Māori were stable; TBI incidence was greater among females, urban residents, and adults aged ≥34 years; and TBI due to falls significantly increased (IRR 1.20, 95% CI 1.03–1.40).</div></div><div><h3>Interpretation</h3><div>Noting increased risks for underestimation due to COVID-19, findings suggest overall TBI incidence rate in NZ was similar in 2021–2022 to 2010–2011, while highlighting changes in TBI distribution. Age-, sex-, area-, ethnic-, and mechanism-specific distributions should be considered when revisiting prevention strategies to reduce TBI incidence.</div></div><div><h3>Funding</h3><div><span>Health Research Council of New Zealand</span> of NZ.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"67 ","pages":"Article 101797"},"PeriodicalIF":8.1,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146037848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and serotype distribution of nasopharyngeal carriage of Streptococcus pneumoniae in Vietnam: a systematic review and meta-analysis 越南肺炎链球菌鼻咽携带的患病率和血清型分布:一项系统回顾和荟萃分析
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 DOI: 10.1016/j.lanwpc.2026.101799
Xuanchen Tao , Ketaki Sharma , Catherine King , Toan Trong Nguyen , Thu-Anh Nguyen , Huyen Thi Thanh Dang , Linh Thuy Duong , Thi Huynh Mai Duong , Phoebe CM. Williams , Sanjay Jayasinghe , Beth Temple , Kim Mulholland , Kristine Macartney
<div><h3>Background</h3><div><em>Streptococcus pneumoniae</em> (<em>S. pneumoniae</em>) is a leading cause of childhood morbidity and mortality worldwide. While pneumococcal conjugate vaccines (PCVs) have significantly reduced the global burden of pneumococcal disease, Vietnam has yet to introduce PCV into their National Immunisation Program. Better understanding of pneumococcal disease in Vietnamese children is key to informing vaccination policy, including PCV product selection. The aim of this study was to assess the prevalence, serotype distribution, and antimicrobial susceptibility patterns of nasopharyngeal carriage of <em>S. pneumoniae</em> among children in Vietnam.</div></div><div><h3>Methods</h3><div>We conducted a systematic review and meta-analysis of <em>S. pneumoniae</em> carriage studies in Vietnamese children under 18 years of age. Seven international biomedical research databases and 13 key Vietnamese-language journals were searched without language or publication date restrictions. The Joanna Briggs Institute critical appraisal tools were used to assess the quality of articles. We extracted data on the prevalence of <em>S. pneumoniae</em> carriage and the serotype distribution. Where available, we also extracted the proportions of isolates that were non-susceptible to selected antibiotics. The pooled prevalence, serotype distribution, and antibiotic resistance rates were calculated with 95% confidence intervals (CIs) using random-effects models.</div></div><div><h3>Findings</h3><div>A total of 1197 studies were searched, of which 594 unique studies were identified and screened. 15 studies, conducted between 1996 and 2020, were included in the systematic review and meta-analysis. The pooled prevalence of nasopharyngeal carriage of <em>S. pneumoniae</em> among Vietnamese children was 33% (95% CI: 28%–39%). The most common vaccine serotypes associated with colonisation were 6A (23%), 19F (17%), 6B (15%), 23F (10%), 14 (8%), and 19A (3%). High non-susceptibility rates were observed for penicillin (64%), macrolides (70%–91%), sulfamethoxazole–trimethoprim (70%), tetracycline (84%), and several other antibiotics. Moderate to low non-susceptibility rates were observed for amoxicillin (22%), amoxicillin-clavulanate (6%), moxifloxacin (1%), vancomycin (1%), and rifampicin (0%).</div></div><div><h3>Interpretation</h3><div>The prevalence of <em>S. pneumoniae</em> nasopharyngeal carriage in children, a surrogate for potential invasive disease, was high in Vietnam, with substantial antimicrobial resistance detected. The predominant serotypes circulating in the community are covered by available PCVs. Inclusion of PCV into the country's National Immunisation Program at the earliest opportunity will have a large impact on childhood disease.</div></div><div><h3>Funding</h3><div><span>Gavi</span>, the <span>Vaccine Alliance</span>, and <span>Australia’s Department of Foreign Affairs and Trade</span> (DFAT) provided funding support for this proje
背景肺炎链球菌(S. pneumoniae)是全球儿童发病和死亡的主要原因。虽然肺炎球菌结合疫苗(PCV)显著减少了肺炎球菌疾病的全球负担,但越南尚未将PCV纳入其国家免疫规划。更好地了解越南儿童的肺炎球菌疾病是告知疫苗接种政策,包括PCV产品选择的关键。本研究的目的是评估越南儿童中肺炎链球菌鼻咽携带的患病率、血清型分布和抗菌药物敏感性模式。方法我们对越南18岁以下儿童肺炎链球菌携带研究进行了系统回顾和荟萃分析。在没有语言或出版日期限制的情况下,检索了7个国际生物医学研究数据库和13种越南语主要期刊。乔安娜布里格斯研究所的关键评估工具被用来评估文章的质量。我们提取了肺炎链球菌携带率和血清型分布的数据。在可能的情况下,我们还提取了对选定抗生素不敏感的分离株的比例。采用随机效应模型,以95%置信区间(ci)计算总患病率、血清型分布和抗生素耐药率。共检索了1197项研究,其中594项独特的研究被确定并筛选。在1996年至2020年间进行的15项研究被纳入系统综述和荟萃分析。越南儿童鼻咽携带肺炎链球菌的总流行率为33% (95% CI: 28%-39%)。与定植相关的最常见疫苗血清型为6A(23%)、19F(17%)、6B(15%)、23F(10%)、14(8%)和19A(3%)。青霉素(64%)、大环内酯类(70% - 91%)、磺胺甲恶唑-甲氧苄啶(70%)、四环素(84%)和其他几种抗生素的非敏感性较高。阿莫西林(22%)、阿莫西林-克拉维酸酯(6%)、莫西沙星(1%)、万古霉素(1%)和利福平(0%)的非敏感性为中低。结论:越南儿童肺炎链球菌(一种潜在侵袭性疾病的替代物)鼻咽携带的流行率很高,并且检测到大量的抗微生物药物耐药性。现有的pcv涵盖了社区流行的主要血清型。尽早将PCV纳入该国的国家免疫规划将对儿童疾病产生重大影响。全球疫苗免疫联盟、疫苗联盟和澳大利亚外交和贸易部为该项目提供了资金支持。
{"title":"Prevalence and serotype distribution of nasopharyngeal carriage of Streptococcus pneumoniae in Vietnam: a systematic review and meta-analysis","authors":"Xuanchen Tao ,&nbsp;Ketaki Sharma ,&nbsp;Catherine King ,&nbsp;Toan Trong Nguyen ,&nbsp;Thu-Anh Nguyen ,&nbsp;Huyen Thi Thanh Dang ,&nbsp;Linh Thuy Duong ,&nbsp;Thi Huynh Mai Duong ,&nbsp;Phoebe CM. Williams ,&nbsp;Sanjay Jayasinghe ,&nbsp;Beth Temple ,&nbsp;Kim Mulholland ,&nbsp;Kristine Macartney","doi":"10.1016/j.lanwpc.2026.101799","DOIUrl":"10.1016/j.lanwpc.2026.101799","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;&lt;em&gt;Streptococcus pneumoniae&lt;/em&gt; (&lt;em&gt;S. pneumoniae&lt;/em&gt;) is a leading cause of childhood morbidity and mortality worldwide. While pneumococcal conjugate vaccines (PCVs) have significantly reduced the global burden of pneumococcal disease, Vietnam has yet to introduce PCV into their National Immunisation Program. Better understanding of pneumococcal disease in Vietnamese children is key to informing vaccination policy, including PCV product selection. The aim of this study was to assess the prevalence, serotype distribution, and antimicrobial susceptibility patterns of nasopharyngeal carriage of &lt;em&gt;S. pneumoniae&lt;/em&gt; among children in Vietnam.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;We conducted a systematic review and meta-analysis of &lt;em&gt;S. pneumoniae&lt;/em&gt; carriage studies in Vietnamese children under 18 years of age. Seven international biomedical research databases and 13 key Vietnamese-language journals were searched without language or publication date restrictions. The Joanna Briggs Institute critical appraisal tools were used to assess the quality of articles. We extracted data on the prevalence of &lt;em&gt;S. pneumoniae&lt;/em&gt; carriage and the serotype distribution. Where available, we also extracted the proportions of isolates that were non-susceptible to selected antibiotics. The pooled prevalence, serotype distribution, and antibiotic resistance rates were calculated with 95% confidence intervals (CIs) using random-effects models.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Findings&lt;/h3&gt;&lt;div&gt;A total of 1197 studies were searched, of which 594 unique studies were identified and screened. 15 studies, conducted between 1996 and 2020, were included in the systematic review and meta-analysis. The pooled prevalence of nasopharyngeal carriage of &lt;em&gt;S. pneumoniae&lt;/em&gt; among Vietnamese children was 33% (95% CI: 28%–39%). The most common vaccine serotypes associated with colonisation were 6A (23%), 19F (17%), 6B (15%), 23F (10%), 14 (8%), and 19A (3%). High non-susceptibility rates were observed for penicillin (64%), macrolides (70%–91%), sulfamethoxazole–trimethoprim (70%), tetracycline (84%), and several other antibiotics. Moderate to low non-susceptibility rates were observed for amoxicillin (22%), amoxicillin-clavulanate (6%), moxifloxacin (1%), vancomycin (1%), and rifampicin (0%).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Interpretation&lt;/h3&gt;&lt;div&gt;The prevalence of &lt;em&gt;S. pneumoniae&lt;/em&gt; nasopharyngeal carriage in children, a surrogate for potential invasive disease, was high in Vietnam, with substantial antimicrobial resistance detected. The predominant serotypes circulating in the community are covered by available PCVs. Inclusion of PCV into the country's National Immunisation Program at the earliest opportunity will have a large impact on childhood disease.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Funding&lt;/h3&gt;&lt;div&gt;&lt;span&gt;Gavi&lt;/span&gt;, the &lt;span&gt;Vaccine Alliance&lt;/span&gt;, and &lt;span&gt;Australia’s Department of Foreign Affairs and Trade&lt;/span&gt; (DFAT) provided funding support for this proje","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"66 ","pages":"Article 101799"},"PeriodicalIF":8.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146037668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Measuring cancer equity globally: harmonising international rural-urban classifications for exploring cancer outcomes 衡量全球癌症公平性:协调国际城乡分类以探索癌症结果
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 DOI: 10.1016/j.lanwpc.2025.101737
Charlene Wright , Sharina Riva , Megan Crichton , Helena Rodi , Hannah Jongebloed , Lucy Leigh , Elizabeth A. Johnston , Rebecca J. Bergin , Anna Chapman , Laura Alston , Fiona Crawford–Williams , Nicolas H. Hart , Joel Rhee , Lan Gao , Kate Gunn , Harry Gasper , Anna Ugalde , Skye Marshall
Geographic disparities in cancer outcomes represent a critical health equity challenge, with rural populations consistently experiencing poorer outcomes than urban populations. The lack of harmonised rurality measures creates substantial barriers to evidence synthesis and has precluded meta-analyses. This perspectives paper discusses concepts of rurality, identifies rurality classification systems used by cancer researchers in OECD countries that can be harmonised with the OECD Extended Typology, and develops recommendations for consistent rural-urban coding. Targeted searches of grey and published literature on cancer policy and rurality classification systems were conducted. The secondary analysis examined studies identified through systematic database searching of OVID Medline, Elsevier Embase, CINAHL, and Web of Science. From 289 studies across 22 OECD countries, twenty-seven rurality classification systems were identified, with eleven systems harmonised to create the Rural-Urban Classification System Harmonisation Framework featuring a consistent five-point rurality scale and standardised urban-rural dichotomisation. Implementation recommendations address system selection, standardised categorisation, and reporting standards. Adopting this harmonisation framework will improve research comparability and strengthen evidence to inform equitable cancer policies.

Funding

Commonwealth of Australia's Medical Research Future Fund (MRF2030313).
癌症结果的地域差异是一项重大的卫生公平挑战,农村人口的结果始终比城市人口差。缺乏统一的农村性措施为证据综合创造了实质性障碍,并妨碍了荟萃分析。这篇远景论文讨论了乡村性的概念,确定了经合组织国家癌症研究人员使用的乡村性分类系统,这些系统可以与经合组织扩展类型学相协调,并提出了一致的农村-城市编码建议。对灰色和已发表的关于癌症政策和农村分类系统的文献进行了有针对性的搜索。二级分析检查了通过系统检索OVID Medline、Elsevier Embase、CINAHL和Web of Science数据库确定的研究。从22个经合组织国家的289项研究中,确定了27个乡村分类系统,其中11个系统协调创建了农村-城市分类系统协调框架,该框架具有一致的五点乡村性量表和标准化的城乡二分法。实施建议涉及系统选择、标准化分类和报告标准。采用这一协调框架将改善研究的可比性,并加强证据,为公平的癌症政策提供信息。澳大利亚联邦医学研究未来基金(MRF2030313)。
{"title":"Measuring cancer equity globally: harmonising international rural-urban classifications for exploring cancer outcomes","authors":"Charlene Wright ,&nbsp;Sharina Riva ,&nbsp;Megan Crichton ,&nbsp;Helena Rodi ,&nbsp;Hannah Jongebloed ,&nbsp;Lucy Leigh ,&nbsp;Elizabeth A. Johnston ,&nbsp;Rebecca J. Bergin ,&nbsp;Anna Chapman ,&nbsp;Laura Alston ,&nbsp;Fiona Crawford–Williams ,&nbsp;Nicolas H. Hart ,&nbsp;Joel Rhee ,&nbsp;Lan Gao ,&nbsp;Kate Gunn ,&nbsp;Harry Gasper ,&nbsp;Anna Ugalde ,&nbsp;Skye Marshall","doi":"10.1016/j.lanwpc.2025.101737","DOIUrl":"10.1016/j.lanwpc.2025.101737","url":null,"abstract":"<div><div>Geographic disparities in cancer outcomes represent a critical health equity challenge, with rural populations consistently experiencing poorer outcomes than urban populations. The lack of harmonised rurality measures creates substantial barriers to evidence synthesis and has precluded meta-analyses. This perspectives paper discusses concepts of rurality, identifies rurality classification systems used by cancer researchers in OECD countries that can be harmonised with the OECD Extended Typology, and develops recommendations for consistent rural-urban coding. Targeted searches of grey and published literature on cancer policy and rurality classification systems were conducted. The secondary analysis examined studies identified through systematic database searching of OVID Medline, Elsevier Embase, CINAHL, and Web of Science. From 289 studies across 22 OECD countries, twenty-seven rurality classification systems were identified, with eleven systems harmonised to create the Rural-Urban Classification System Harmonisation Framework featuring a consistent five-point rurality scale and standardised urban-rural dichotomisation. Implementation recommendations address system selection, standardised categorisation, and reporting standards. Adopting this harmonisation framework will improve research comparability and strengthen evidence to inform equitable cancer policies.</div></div><div><h3>Funding</h3><div>Commonwealth of Australia's <span>Medical Research Future Fund</span> (MRF2030313).</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"66 ","pages":"Article 101737"},"PeriodicalIF":8.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of rurality status with all-cause and cancer-specific survival: a systematic review and meta-analysis adjusting for clinical factors, demographics, and geographical remoteness 农村状况与全因和癌症特异性生存的关系:一项系统回顾和荟萃分析,调整了临床因素、人口统计学和地理偏远
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 DOI: 10.1016/j.lanwpc.2025.101744
Skye Marshall , Charlene Wright , Lucy Leigh , Sharina Riva , Megan Crichton , Helena Rodi , Hannah Jongebloed , Elizabeth A. Johnston , Rebecca J. Bergin , Anna Chapman , Fiona Crawford-Williams , Nicolas H. Hart , Laura Alston , Joel Rhee , Lan Gao , Kate Gunn , Anna Ugalde
The association of rurality status with cancer survival has not been consistently reported. In people diagnosed with cancer, this review aims to determine the association of rural and remote living with survival as compared to urban living, and to determine the modifying effects of geographical, medical, demographic, and socioeconomic factors on cancer survival. A systematic review with meta-analysis and meta-regression was conducted, searching four databases in August 2024. Observational cohort studies were eligible if they reported all-cause or cancer-specific survival according to rurality status in Organisation for Economic Co-operation and Development (OECD) countries. All ages, sexes, and cancer types were eligible. Risk of bias was assessed using the Newcastle–Ottawa Scale and pooled models were evaluated using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE). Meta-analyses and meta-regressions were performed using R statistical environment. 37 studies reporting on 110 comparator groups were included. People with cancer in rural areas were at a survival disadvantage compared to people in urban areas, with 15% lower odds of all-cause survival (OR 0.85 [95% CI 0.74, 0.97]) and 10% lower odds of cancer-specific survival (OR: 0.90 [95% CI 0.86, 0.95]). Cancer type and degree of geographical remoteness were consistent modifiers of survival in univariable and multivariable regression. Increasing degree of geographical remoteness was associated with lower odds of all-cause survival (OR 0.28 [95% CI 0.12–0.67]). People living in rural areas diagnosed with cancer have lower odds of all-cause and cancer-specific survival which worsened with increasing geographical remoteness. Type of cancer was consistently found to be a modifying factor of cancer survival. Increased recognition of people living in rural areas as a priority population group in health and cancer policies is needed to improve cancer equity.

Funding

Commonwealth of Australia's Medical Research Future Fund (MRF2030313).
农村状况与癌症生存的关系并没有一致的报道。在被诊断为癌症的人群中,本综述旨在确定与城市生活相比,农村和偏远生活与生存的关系,并确定地理、医学、人口统计学和社会经济因素对癌症生存的修正作用。于2024年8月检索4个数据库,采用meta分析和meta回归方法进行系统评价。观察性队列研究如果根据经济合作与发展组织(OECD)国家的农村状况报告了全因或癌症特异性生存率,则符合条件。所有年龄、性别和癌症类型都符合条件。使用纽卡斯尔-渥太华量表评估偏倚风险,使用推荐、评估、发展和评估分级(GRADE)评估合并模型。采用R统计环境进行meta分析和meta回归。纳入了涉及110个比较组的37项研究。农村地区的癌症患者与城市地区的患者相比处于生存劣势,全因生存几率低15% (OR 0.85 [95% CI 0.74, 0.97]),癌症特异性生存几率低10% (OR: 0.90 [95% CI 0.86, 0.95])。在单变量和多变量回归中,癌症类型和地理偏远程度是生存率的一致修饰因素。地理偏远程度的增加与全因生存率的降低相关(OR 0.28 [95% CI 0.12-0.67])。生活在农村地区被诊断患有癌症的人的全因生存率和癌症特异性生存率较低,这种情况随着地理位置的偏远而恶化。癌症类型一直被发现是癌症生存的一个修饰因素。为了改善癌症公平,需要更多地认识到生活在农村地区的人是保健和癌症政策中的优先人口群体。澳大利亚联邦医学研究未来基金(MRF2030313)。
{"title":"Association of rurality status with all-cause and cancer-specific survival: a systematic review and meta-analysis adjusting for clinical factors, demographics, and geographical remoteness","authors":"Skye Marshall ,&nbsp;Charlene Wright ,&nbsp;Lucy Leigh ,&nbsp;Sharina Riva ,&nbsp;Megan Crichton ,&nbsp;Helena Rodi ,&nbsp;Hannah Jongebloed ,&nbsp;Elizabeth A. Johnston ,&nbsp;Rebecca J. Bergin ,&nbsp;Anna Chapman ,&nbsp;Fiona Crawford-Williams ,&nbsp;Nicolas H. Hart ,&nbsp;Laura Alston ,&nbsp;Joel Rhee ,&nbsp;Lan Gao ,&nbsp;Kate Gunn ,&nbsp;Anna Ugalde","doi":"10.1016/j.lanwpc.2025.101744","DOIUrl":"10.1016/j.lanwpc.2025.101744","url":null,"abstract":"<div><div>The association of rurality status with cancer survival has not been consistently reported. In people diagnosed with cancer, this review aims to determine the association of rural and remote living with survival as compared to urban living, and to determine the modifying effects of geographical, medical, demographic, and socioeconomic factors on cancer survival. A systematic review with meta-analysis and meta-regression was conducted, searching four databases in August 2024. Observational cohort studies were eligible if they reported all-cause or cancer-specific survival according to rurality status in Organisation for Economic Co-operation and Development (OECD) countries. All ages, sexes, and cancer types were eligible. Risk of bias was assessed using the Newcastle–Ottawa Scale and pooled models were evaluated using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE). Meta-analyses and meta-regressions were performed using R statistical environment. 37 studies reporting on 110 comparator groups were included. People with cancer in rural areas were at a survival disadvantage compared to people in urban areas, with 15% lower odds of all-cause survival (OR 0.85 [95% CI 0.74, 0.97]) and 10% lower odds of cancer-specific survival (OR: 0.90 [95% CI 0.86, 0.95]). Cancer type and degree of geographical remoteness were consistent modifiers of survival in univariable and multivariable regression. Increasing degree of geographical remoteness was associated with lower odds of all-cause survival (OR 0.28 [95% CI 0.12–0.67]). People living in rural areas diagnosed with cancer have lower odds of all-cause and cancer-specific survival which worsened with increasing geographical remoteness. Type of cancer was consistently found to be a modifying factor of cancer survival. Increased recognition of people living in rural areas as a priority population group in health and cancer policies is needed to improve cancer equity.</div></div><div><h3>Funding</h3><div><span>Commonwealth of Australia's Medical Research Future</span> Fund (MRF2030313).</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"66 ","pages":"Article 101744"},"PeriodicalIF":8.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re-imagining Global Health: perspectives from the next generation in the Pacific region 重新构想全球卫生:来自太平洋区域下一代的观点
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 DOI: 10.1016/j.lanwpc.2025.101787
S. Boladuadua , F. Langridge , R. Qin , R. Ng Shiu , J. McCool , J. Mani , J. Kailawadoko , E.A.-L. Holt
This viewpoint piece examines Global Health in the Pacific region. The purpose of the article is to provide a Pacific, female perspective to Global Health by considering the history, context, and current practices in the region. Reflecting on a history of colonialism and exclusion of Indigenous Pacific Peoples worldviews, we re-imagine a future that prioritises Pacific aspirations. Central to this shift is a Global Health approach that ensures Pacific priorities, leadership and aspirations through four action areas of sovereignty, integrating worldviews, connectivity, and equity and participation. We draw on examples of lived experiences that include health systems strengthening, research and policy.
这篇观点文章审查了太平洋地区的全球卫生。本文的目的是通过考虑该地区的历史、背景和当前做法,为全球卫生提供一个太平洋女性的视角。反思殖民主义历史和排斥太平洋土著人民世界观,我们重新设想一个优先考虑太平洋愿望的未来。这一转变的核心是全球卫生方针,通过主权、世界观一体化、连通性、公平和参与四个行动领域确保太平洋的优先事项、领导和愿望。我们借鉴了包括加强卫生系统、研究和政策在内的生活经验实例。
{"title":"Re-imagining Global Health: perspectives from the next generation in the Pacific region","authors":"S. Boladuadua ,&nbsp;F. Langridge ,&nbsp;R. Qin ,&nbsp;R. Ng Shiu ,&nbsp;J. McCool ,&nbsp;J. Mani ,&nbsp;J. Kailawadoko ,&nbsp;E.A.-L. Holt","doi":"10.1016/j.lanwpc.2025.101787","DOIUrl":"10.1016/j.lanwpc.2025.101787","url":null,"abstract":"<div><div>This viewpoint piece examines Global Health in the Pacific region. The purpose of the article is to provide a Pacific, female perspective to Global Health by considering the history, context, and current practices in the region. Reflecting on a history of colonialism and exclusion of Indigenous Pacific Peoples worldviews, we re-imagine a future that prioritises Pacific aspirations. Central to this shift is a Global Health approach that ensures Pacific priorities, leadership and aspirations through four action areas of sovereignty, integrating worldviews, connectivity, and equity and participation. We draw on examples of lived experiences that include health systems strengthening, research and policy.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"66 ","pages":"Article 101787"},"PeriodicalIF":8.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145926784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The potential for dementia prevention in Japan: a population attributable fraction calculation for 14 modifiable risk factors and estimates of the impact of risk factor reductions 日本预防痴呆症的潜力:14种可改变危险因素的人口归因分数计算和减少危险因素的影响估计
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 DOI: 10.1016/j.lanwpc.2025.101792
Koichiro Wasano , Kasper Jørgensen

Background

As dementia prevalence increases globally, preventive strategies targeting modifiable risk factors have become increasingly important. In Japan, with its super-ageing society, dementia is the leading cause of increased disability-adjusted life years among older adults. This study quantified the contribution of 14 potentially modifiable risk factors for dementia in older adults using Japan-specific prevalence data.

Methods

We calculated population attributable fractions (PAFs) and potential impact fractions (PIFs) using recent publicly available prevalence data from national surveys and cohort studies in Japan, and relative risks and communality weights from the 2024 Lancet Commission report on dementia. We then modelled how 10% and 20% reductions in each risk factor would affect national dementia prevalence.

Findings

The weighted combined PAF for all 14 risk factors was 38.9%, indicating that nearly 4 in 10 dementia cases in Japan might be preventable. Hearing loss (6.7%), physical inactivity (6.0%), and high LDL cholesterol (4.5%) were the largest contributors. Reducing all risk factors by 10% could prevent ∼208,000 dementia cases; reducing them by 20% could prevent ∼407,000 cases.

Interpretation

Dementia preventive efforts in Japan should prioritise hearing care, physical activity, and metabolic health. Japan-specific data confirmed that hearing loss is a leading contributor to dementia, underscoring the urgency to increase public awareness and access to hearing interventions.

Funding

The Royal Danish Embassy in Japan, Danish Ministry of Foreign Affairs, Danish Ministry of Health, and Japan Agency for Medical Research and Development funded this study.
随着全球痴呆症患病率的上升,针对可改变风险因素的预防策略变得越来越重要。在超级老龄化社会的日本,痴呆症是老年人残疾调整寿命年数增加的主要原因。本研究使用日本特有的患病率数据量化了14种可能改变的老年人痴呆风险因素的贡献。方法:我们利用最近日本国家调查和队列研究中可公开获得的患病率数据,以及2024年《柳叶刀》委员会痴呆报告中的相对风险和社区权重,计算了人口归因分数(paf)和潜在影响分数(pif)。然后,我们模拟了每种风险因素减少10%和20%将如何影响全国痴呆症患病率。研究结果:所有14个风险因素的加权综合PAF为38.9%,表明日本近40%的痴呆病例是可以预防的。听力损失(6.7%)、缺乏运动(6.0%)和高LDL胆固醇(4.5%)是最大的致病因素。将所有危险因素减少10%,可以预防208,000例痴呆病例;如果减少20%,就可以预防40.7万例病例。日本的痴呆症预防工作应优先考虑听力保健、身体活动和代谢健康。日本特有的数据证实,听力损失是导致痴呆症的主要因素,强调了提高公众意识和获得听力干预措施的紧迫性。丹麦驻日本皇家大使馆、丹麦外交部、丹麦卫生部和日本医学研究与开发机构资助了这项研究。
{"title":"The potential for dementia prevention in Japan: a population attributable fraction calculation for 14 modifiable risk factors and estimates of the impact of risk factor reductions","authors":"Koichiro Wasano ,&nbsp;Kasper Jørgensen","doi":"10.1016/j.lanwpc.2025.101792","DOIUrl":"10.1016/j.lanwpc.2025.101792","url":null,"abstract":"<div><h3>Background</h3><div>As dementia prevalence increases globally, preventive strategies targeting modifiable risk factors have become increasingly important. In Japan, with its super-ageing society, dementia is the leading cause of increased disability-adjusted life years among older adults. This study quantified the contribution of 14 potentially modifiable risk factors for dementia in older adults using Japan-specific prevalence data.</div></div><div><h3>Methods</h3><div>We calculated population attributable fractions (PAFs) and potential impact fractions (PIFs) using recent publicly available prevalence data from national surveys and cohort studies in Japan, and relative risks and communality weights from the 2024 <em>Lancet</em> Commission report on dementia. We then modelled how 10% and 20% reductions in each risk factor would affect national dementia prevalence.</div></div><div><h3>Findings</h3><div>The weighted combined PAF for all 14 risk factors was 38.9%, indicating that nearly 4 in 10 dementia cases in Japan might be preventable. Hearing loss (6.7%), physical inactivity (6.0%), and high LDL cholesterol (4.5%) were the largest contributors. Reducing all risk factors by 10% could prevent ∼208,000 dementia cases; reducing them by 20% could prevent ∼407,000 cases.</div></div><div><h3>Interpretation</h3><div>Dementia preventive efforts in Japan should prioritise hearing care, physical activity, and metabolic health. Japan-specific data confirmed that hearing loss is a leading contributor to dementia, underscoring the urgency to increase public awareness and access to hearing interventions.</div></div><div><h3>Funding</h3><div>The <span>Royal Danish Embassy in Japan</span>, <span>Danish Ministry of Foreign Affairs</span>, <span>Danish Ministry of Health</span>, and <span>Japan Agency for Medical Research and Development</span> funded this study.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"66 ","pages":"Article 101792"},"PeriodicalIF":8.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular disease risk prediction in multi-ethnic Asian populations: evidence from two population-based cohorts in Singapore 多种族亚洲人群心血管疾病风险预测:来自新加坡两个基于人群的队列的证据
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 DOI: 10.1016/j.lanwpc.2025.101794
Charlie G.Y. Lim , Crystal C.Y. Chong , Yvonne H.M. Wong , Jiali Yao , Stefen Ma , John C. Chambers , Khung Keong Yeo , E Shyong Tai , Jasper Tromp , Rob M. van Dam , Saima Hilal , Charumathi Sabanayagam , Ching-Yu Cheng , Xueling Sim

Background

The rising burden of cardiovascular diseases (CVD) in Asia requires risk assessment tools tailored to Asian populations. Therefore, we recalibrated the ACC/AHA Pooled Cohort Equations for non-Hispanic Whites (PCE-W) and compared its performance in predicting 10-year CVD risk with two other established CVD prediction models that have been recently recalibrated for Asian populations.

Methods

We used data from the Singapore Multi-Ethnic Cohort (MEC1) and the Singapore Epidemiology of Eye Diseases (SEED) cohort comprising ethnic Chinese, Indian, and Malay participants. The PCE-W was recalibrated using data from MEC1, externally validated in the SEED cohort, and compared against the Singapore-modified Framingham Risk Score (SG-FRS-2023) and the SCORE2 Asia–Pacific model using the concordance index (C-index). Calibration was assessed using the calibration-in-the-large method, the calibration slope, and a goodness-of-fit test.

Findings

All three models demonstrated possibly helpful to clearly useful discrimination in MEC1 and SEED, with overall C-indices ranging from 0.728 to 0.811. The recalibrated PCE-W outperformed the original PCE-W in MEC1 and SEED, although some misestimations remained among Chinese men and women and Malay women (calibration-in-the-large ranged from −0.479 to 0.260). The SG-FRS-2023 displayed generally satisfactory calibration across both MEC1 and SEED but tended to overestimate risk in Chinese (calibration-in-the-large −0.671) and Indian men (calibration-in-the-large −0.214) in the SEED cohort. The SCORE2 Asia–Pacific model performed satisfactorily among Indians but overestimated risk in Chinese (calibration-in-the-large ranged from −0.570 to −1.185) and showed poor model fit in Malays.

Interpretation

The recalibrated PCE-W, SG-FRS-2023, and SCORE2 Asia–Pacific model demonstrated possibly helpful to clearly useful discrimination across two multi-ethnic cohorts in Singapore. In terms of calibration, the recalibrated PCE-W and SG-FRS-2023, both recalibrated using local data, performed better than the SCORE2 Asia–Pacific model. Our study supports the use of the established CVD prediction models in Asian populations following appropriate local recalibration.

Funding

This work was supported by the Singapore Ministry of Health’s National Medical Research Council and the Singapore Biomedical Research Council.
亚洲心血管疾病(CVD)负担的增加需要针对亚洲人群的风险评估工具。因此,我们重新校准了非西班牙裔白人的ACC/AHA合并队列方程(PCE-W),并将其在预测10年心血管疾病风险方面的表现与最近为亚洲人群重新校准的其他两种已建立的心血管疾病预测模型进行了比较。方法我们使用来自新加坡多民族队列(MEC1)和新加坡眼病流行病学队列(SEED)的数据,该队列包括华人、印度人和马来人。PCE-W使用来自MEC1的数据重新校准,在SEED队列中进行外部验证,并使用一致性指数(C-index)与新加坡修改的Framingham风险评分(SG-FRS-2023)和SCORE2亚太模型进行比较。采用大规模校准法、校准斜率和拟合优度检验对校准进行评估。结果表明,这三种模型可能有助于明确MEC1和SEED的有用区分,总c指数在0.728 ~ 0.811之间。重新校准的PCE-W在MEC1和SEED中的表现优于原始PCE-W,尽管在华人男性和女性以及马来女性中仍然存在一些错误估计(校准范围为- 0.479至0.260)。SG-FRS-2023在MEC1和SEED中显示出总体满意的校准,但在SEED队列中,中国男性(校准-大- 0.671)和印度男性(校准-大- 0.214)倾向于高估风险。SCORE2亚太模型在印度人中表现令人满意,但在华人中高估了风险(大校准范围从- 0.570到- 1.185),在马来人中显示出较差的模型拟合。重新校准的PCE-W、SG-FRS-2023和SCORE2亚太模型显示可能有助于在新加坡的两个多民族队列中明确有用的歧视。在校准方面,重新校准的PCE-W和SG-FRS-2023均使用当地数据进行重新校准,其性能优于SCORE2亚太模型。我们的研究支持在适当的当地重新校准后,在亚洲人群中使用已建立的CVD预测模型。这项工作得到了新加坡卫生部国家医学研究委员会和新加坡生物医学研究委员会的支持。
{"title":"Cardiovascular disease risk prediction in multi-ethnic Asian populations: evidence from two population-based cohorts in Singapore","authors":"Charlie G.Y. Lim ,&nbsp;Crystal C.Y. Chong ,&nbsp;Yvonne H.M. Wong ,&nbsp;Jiali Yao ,&nbsp;Stefen Ma ,&nbsp;John C. Chambers ,&nbsp;Khung Keong Yeo ,&nbsp;E Shyong Tai ,&nbsp;Jasper Tromp ,&nbsp;Rob M. van Dam ,&nbsp;Saima Hilal ,&nbsp;Charumathi Sabanayagam ,&nbsp;Ching-Yu Cheng ,&nbsp;Xueling Sim","doi":"10.1016/j.lanwpc.2025.101794","DOIUrl":"10.1016/j.lanwpc.2025.101794","url":null,"abstract":"<div><h3>Background</h3><div>The rising burden of cardiovascular diseases (CVD) in Asia requires risk assessment tools tailored to Asian populations. Therefore, we recalibrated the ACC/AHA Pooled Cohort Equations for non-Hispanic Whites (PCE-W) and compared its performance in predicting 10-year CVD risk with two other established CVD prediction models that have been recently recalibrated for Asian populations.</div></div><div><h3>Methods</h3><div>We used data from the Singapore Multi-Ethnic Cohort (MEC1) and the Singapore Epidemiology of Eye Diseases (SEED) cohort comprising ethnic Chinese, Indian, and Malay participants. The PCE-W was recalibrated using data from MEC1, externally validated in the SEED cohort, and compared against the Singapore-modified Framingham Risk Score (SG-FRS-2023) and the SCORE2 Asia–Pacific model using the concordance index (C-index). Calibration was assessed using the calibration-in-the-large method, the calibration slope, and a goodness-of-fit test.</div></div><div><h3>Findings</h3><div>All three models demonstrated possibly helpful to clearly useful discrimination in MEC1 and SEED, with overall C-indices ranging from 0.728 to 0.811. The recalibrated PCE-W outperformed the original PCE-W in MEC1 and SEED, although some misestimations remained among Chinese men and women and Malay women (calibration-in-the-large ranged from −0.479 to 0.260). The SG-FRS-2023 displayed generally satisfactory calibration across both MEC1 and SEED but tended to overestimate risk in Chinese (calibration-in-the-large −0.671) and Indian men (calibration-in-the-large −0.214) in the SEED cohort. The SCORE2 Asia–Pacific model performed satisfactorily among Indians but overestimated risk in Chinese (calibration-in-the-large ranged from −0.570 to −1.185) and showed poor model fit in Malays.</div></div><div><h3>Interpretation</h3><div>The recalibrated PCE-W, SG-FRS-2023, and SCORE2 Asia–Pacific model demonstrated possibly helpful to clearly useful discrimination across two multi-ethnic cohorts in Singapore. In terms of calibration, the recalibrated PCE-W and SG-FRS-2023, both recalibrated using local data, performed better than the SCORE2 Asia–Pacific model. Our study supports the use of the established CVD prediction models in Asian populations following appropriate local recalibration.</div></div><div><h3>Funding</h3><div>This work was supported by the Singapore <span>Ministry of Health’s National Medical Research</span> Council and the Singapore <span>Biomedical Research Council</span>.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"66 ","pages":"Article 101794"},"PeriodicalIF":8.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145884746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spatio-temporal patterns of tuberculosis revealed by routine Mycobacterium tuberculosis sequencing in Australia: an extended patient cohort analysis (2017–2023) 澳大利亚常规结核分枝杆菌测序揭示的结核病时空格局:一项扩展的患者队列分析(2017-2023)
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 DOI: 10.1016/j.lanwpc.2025.101784
Xiaomei Zhang , Carl J.E. Suster , Eby M. Sim , Connie Lam , Elena Martinez , Taryn Crighton , Ellen J. Donnan , Ben J. Marais , Vitali Sintchenko

Background

Tuberculosis (TB) remains a global public health challenge. Even low-incidence countries, like Australia, are struggling to achieve ambitious targets to eliminate local TB transmission. Whole genome sequencing (WGS) of Mycobacterium tuberculosis facilitates accurate transmission tracking, but its integration into public health response remains limited. This study conducted spatiotemporal analyses of routine WGS data and assessed its potential value to guide programmatic TB control responses.

Methods

WGS and geolocation data from 2492 M. tuberculosis isolates were examined, representing 94.9% of culture-confirmed and 64.2% of all notified TB cases in New South Wales, Australia (2017–2023). We performed genomic clustering, assessed genetic and geographic distances between cases, and applied Bayesian dated phylogeny to estimate the likely time of strain introduction.

Findings

Most notified TB cases were successfully sequenced and geolocated, with 88.3% (2200/2492) residing in metropolitan Sydney. The local health districts (LHDs) with the highest case counts were South Western (523/2492, 21.0%) and Western Sydney (476/2492, 19.1%). Using a 5-SNP threshold, WGS identified 106 putative transmission clusters involving 288 cases (11.7%), with 50% spanning multiple LHDs. Eight large clusters (≥5 members) were identified, containing 64 cases (2.6%). The largest cluster (17 members) was caused by a Lineage 1 strain, although most large clusters were associated with Lineage 2 strains; two were isoniazid resistant. There was poor correlation between genetic and geographic distances, which showed some improvement with removal of outliers. Most recent common ancestor estimates suggested recent introduction of strains associated with local transmission. Strain clustering and lineage-through-time analyses revealed temporal patterns in cluster expansion and contraction, facilitating accurate monitoring of cluster spread across all of NSW.

Interpretation

The findings demonstrate the added value of integrating genomic and spatiotemporal clustering data to detect persistent transmission and guide targeted interventions to pursue the aspirational goal of “zero local TB transmission”.

Funding

NHMRC Centre for Research Excellence in Tuberculosis (www.tbcre.org.au) and New South Wales Health Prevention Research Support Program.
结核病(TB)仍然是一项全球公共卫生挑战。即使是像澳大利亚这样的低发病率国家,也在努力实现消除当地结核病传播的宏伟目标。结核分枝杆菌的全基因组测序(WGS)有助于准确追踪传播,但将其整合到公共卫生应对中仍然有限。本研究对常规WGS数据进行了时空分析,并评估了其对指导规划结核控制反应的潜在价值。方法分析2017-2023年澳大利亚新南威尔士州2492株结核分枝杆菌的swgs和地理定位数据,分别占培养确诊病例的94.9%和报告结核病例的64.2%。我们进行了基因组聚类,评估了病例之间的遗传和地理距离,并应用贝叶斯时间系统发育来估计菌株引入的可能时间。大多数报告的结核病例成功测序和定位,其中88.3%(2200/2492)居住在悉尼大都会。病例数最高的地方卫生区是西南区(523/2492,21.0%)和西悉尼区(476/2492,19.1%)。使用5-SNP阈值,WGS确定了106个假定的传播集群,涉及288例(11.7%),其中50%跨越多个lhd。共发现8个大集群(≥5个成员),共64例(2.6%)。最大的集群(17个成员)是由谱系1菌株引起的,尽管大多数大型集群与谱系2菌株有关;其中2例对异烟肼耐药。遗传距离与地理距离之间的相关性较差,在去除异常值后,这种相关性有所改善。最近的共同祖先估计表明,最近引入的菌株与当地传播有关。菌株聚类和时间谱系分析揭示了集群扩张和收缩的时间模式,有助于准确监测整个新南威尔士州的集群传播。研究结果表明,整合基因组和时空聚类数据在检测持续传播和指导有针对性的干预措施以实现“本地零结核病传播”的理想目标方面具有附加价值。资助nhmrc结核病卓越研究中心(www.tbcre.org.au)和新南威尔士州健康预防研究支助方案。
{"title":"Spatio-temporal patterns of tuberculosis revealed by routine Mycobacterium tuberculosis sequencing in Australia: an extended patient cohort analysis (2017–2023)","authors":"Xiaomei Zhang ,&nbsp;Carl J.E. Suster ,&nbsp;Eby M. Sim ,&nbsp;Connie Lam ,&nbsp;Elena Martinez ,&nbsp;Taryn Crighton ,&nbsp;Ellen J. Donnan ,&nbsp;Ben J. Marais ,&nbsp;Vitali Sintchenko","doi":"10.1016/j.lanwpc.2025.101784","DOIUrl":"10.1016/j.lanwpc.2025.101784","url":null,"abstract":"<div><h3>Background</h3><div>Tuberculosis (TB) remains a global public health challenge. Even low-incidence countries, like Australia, are struggling to achieve ambitious targets to eliminate local TB transmission. Whole genome sequencing (WGS) of <em>Mycobacterium tuberculosis</em> facilitates accurate transmission tracking, but its integration into public health response remains limited. This study conducted spatiotemporal analyses of routine WGS data and assessed its potential value to guide programmatic TB control responses.</div></div><div><h3>Methods</h3><div>WGS and geolocation data from 2492 <em>M. tuberculosis</em> isolates were examined, representing 94.9% of culture-confirmed and 64.2% of all notified TB cases in New South Wales, Australia (2017–2023). We performed genomic clustering, assessed genetic and geographic distances between cases, and applied Bayesian dated phylogeny to estimate the likely time of strain introduction.</div></div><div><h3>Findings</h3><div>Most notified TB cases were successfully sequenced and geolocated, with 88.3% (2200/2492) residing in metropolitan Sydney. The local health districts (LHDs) with the highest case counts were South Western (523/2492, 21.0%) and Western Sydney (476/2492, 19.1%). Using a 5-SNP threshold, WGS identified 106 putative transmission clusters involving 288 cases (11.7%), with 50% spanning multiple LHDs. Eight large clusters (≥5 members) were identified, containing 64 cases (2.6%). The largest cluster (17 members) was caused by a Lineage 1 strain, although most large clusters were associated with Lineage 2 strains; two were isoniazid resistant. There was poor correlation between genetic and geographic distances, which showed some improvement with removal of outliers. Most recent common ancestor estimates suggested recent introduction of strains associated with local transmission. Strain clustering and lineage-through-time analyses revealed temporal patterns in cluster expansion and contraction, facilitating accurate monitoring of cluster spread across all of NSW.</div></div><div><h3>Interpretation</h3><div>The findings demonstrate the added value of integrating genomic and spatiotemporal clustering data to detect persistent transmission and guide targeted interventions to pursue the aspirational goal of “zero local TB transmission”.</div></div><div><h3>Funding</h3><div>NHMRC Centre for <span>Research Excellence in Tuberculosis</span> (<span><span>www.tbcre.org.au</span><svg><path></path></svg></span>) and <span>New South Wales Health Prevention Research</span> Support Program.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"66 ","pages":"Article 101784"},"PeriodicalIF":8.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145926782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation strategies for evidence-based healthcare interventions in rural and remote settings: a scoping review 农村和偏远地区循证医疗保健干预措施的实施战略:范围审查
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 DOI: 10.1016/j.lanwpc.2025.101732
Anna Chapman , Cadeyrn J. Gaskin , Hannah Beks , Charlene Wright , Skye Marshall , Elizabeth A. Johnston , Rebecca J. Bergin , Sharina Riva , Fiona Crawford-Williams , Camille E. Short , Nicole Kiss , Sze Lin Yoong , Nicolas H. Hart , Anna Wong Shee , Helena Rodi , Hannah Jongebloed , Anna Ugalde
Globally, people living in rural and remote areas experience poorer healthcare access and outcomes than urban populations. Applying implementation strategies that support the translation of evidence-based healthcare interventions may help reduce these inequities; however, real-world implementation is complex, and it remains unclear how strategies are applied and tailored to rural and remote contexts. This scoping review synthesised evidence on implementation strategies for healthcare interventions in rural and remote settings of high-income countries. Five databases (Ovid MEDLINE, Embase, Cochrane CENTRAL, CINAHL, Web of Science) were searched for peer-reviewed studies published between 1/1/2000 and 25/10/2024. Extracted data were synthesised using a descriptive narrative approach. From 11,887 records, 78 papers (75 studies) met inclusion criteria. Implementation efforts were multifaceted, commonly drawing on strategies from three Expert Recommendations for Implementing Change clusters: train and educate stakeholders (n = 70, 93%), use evaluative and iterative strategies (n = 55, 73%), and develop stakeholder interrelationships (n = 48, 64%). Few studies (n = 21; 28%) reported rural-specific design features. Although implementation in rural and remote contexts has focused on provider-level strategies, there is a need to also address system-level determinants to implementation. Context-specific design, meaningful engagement with local communities and stakeholders, and clearer reporting are essential to optimise implementation and reduce rural-urban health disparities.
在全球范围内,与城市人口相比,生活在农村和偏远地区的人口获得医疗保健的机会和结果更差。实施支持循证医疗干预措施转化的实施战略可能有助于减少这些不公平现象;然而,现实世界的实施是复杂的,目前尚不清楚如何将战略应用于农村和偏远地区。这项范围审查综合了高收入国家农村和偏远地区卫生保健干预措施实施战略的证据。检索了5个数据库(Ovid MEDLINE, Embase, Cochrane CENTRAL, CINAHL, Web of Science),检索了2000年1月1日至2024年10月25日发表的同行评议研究。提取的数据使用描述性叙述方法进行综合。从11,887份记录中,78篇论文(75项研究)符合纳入标准。实施工作是多方面的,通常从实施变革集群的三个专家建议中借鉴策略:培训和教育利益相关者(n = 70, 93%),使用评估和迭代策略(n = 55, 73%),发展利益相关者之间的关系(n = 48, 64%)。少数研究(n = 21; 28%)报告了农村特有的设计特征。尽管农村和偏远地区的实施侧重于提供者层面的战略,但也需要解决实施的系统层面决定因素。针对具体情况设计、与当地社区和利益攸关方进行有意义的接触以及更明确的报告,对于优化执行和缩小城乡卫生差距至关重要。
{"title":"Implementation strategies for evidence-based healthcare interventions in rural and remote settings: a scoping review","authors":"Anna Chapman ,&nbsp;Cadeyrn J. Gaskin ,&nbsp;Hannah Beks ,&nbsp;Charlene Wright ,&nbsp;Skye Marshall ,&nbsp;Elizabeth A. Johnston ,&nbsp;Rebecca J. Bergin ,&nbsp;Sharina Riva ,&nbsp;Fiona Crawford-Williams ,&nbsp;Camille E. Short ,&nbsp;Nicole Kiss ,&nbsp;Sze Lin Yoong ,&nbsp;Nicolas H. Hart ,&nbsp;Anna Wong Shee ,&nbsp;Helena Rodi ,&nbsp;Hannah Jongebloed ,&nbsp;Anna Ugalde","doi":"10.1016/j.lanwpc.2025.101732","DOIUrl":"10.1016/j.lanwpc.2025.101732","url":null,"abstract":"<div><div>Globally, people living in rural and remote areas experience poorer healthcare access and outcomes than urban populations. Applying implementation strategies that support the translation of evidence-based healthcare interventions may help reduce these inequities; however, real-world implementation is complex, and it remains unclear how strategies are applied and tailored to rural and remote contexts. This scoping review synthesised evidence on implementation strategies for healthcare interventions in rural and remote settings of high-income countries. Five databases (Ovid MEDLINE, Embase, Cochrane CENTRAL, CINAHL, Web of Science) were searched for peer-reviewed studies published between 1/1/2000 and 25/10/2024. Extracted data were synthesised using a descriptive narrative approach. From 11,887 records, 78 papers (75 studies) met inclusion criteria. Implementation efforts were multifaceted, commonly drawing on strategies from three Expert Recommendations for Implementing Change clusters: <em>train and educate stakeholders</em> (n = 70, 93%), <em>use evaluative and iterative strategies</em> (n = 55, 73%), and <em>develop stakeholder interrelationships</em> (n = 48, 64%). Few studies (n = 21; 28%) reported rural-specific design features. Although implementation in rural and remote contexts has focused on provider-level strategies, there is a need to also address system-level determinants to implementation. Context-specific design, meaningful engagement with local communities and stakeholders, and clearer reporting are essential to optimise implementation and reduce rural-urban health disparities.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"66 ","pages":"Article 101732"},"PeriodicalIF":8.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can administrative data be used for a national register of hospitalised stroke patients? A New Zealand validation study 行政数据可以用于卒中住院患者的全国登记吗?一项新西兰验证性研究
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 DOI: 10.1016/j.lanwpc.2025.101768
Marine Corbin , Hayley J. Denison , Jeroen Douwes , Mina Whyte , Stephanie G. Thompson , Matire Harwood , Alan Davis , John N. Fink , P. Alan Barber , John H. Gommans , Dominique A. Cadilhac , William M. Levack , Harry McNaughton , Joosup Kim , Valery L. Feigin , Anna Ranta

Background

Using community-based incidence studies and clinical registries to assess stroke care and outcomes is resource intensive and often geographically limited. Linked administrative data are lower-cost and wider-reaching, but potentially less accurate and complete. This study compared administrative data to national hospital-based study data to assess whether administrative data represents a valid alternative.

Methods

We linked and compared data from the REGIONS Care Study, a New Zealand nationwide observational study, with administrative data from Statistics New Zealand’s Integrated Data Infrastructure (IDI). Sensitivity, specificity, positive predictive value, and Cohen’s kappa coefficient were used to assess case identification, risk factors, post-stroke outcomes, and interventions as applicable. Additional audits explored the validity of IDI ‘true false positives.’

Findings

From May to July 2018, 1719 patients with stroke were captured in REGIONS Care and 1833 in the IDI. Using REGIONS Care as the reference standard, the sensitivity of the IDI for stroke case identification was 83% and the positive predictive value 77%. There were 300 false-negatives and 414 false positives. The audit of two hospitals showed that some cases identified in IDI but excluded by REGIONS were actual strokes. For stroke risk factors, the IDI showed high sensitivity and specificity for diabetes (93% and 91%, respectively), atrial fibrillation (87% and 90%), and smoking (71% and 97%) but lower specificity for hypertension (61%), and dyslipidaemia (52%). A derived IDI favourable outcome measure showed good agreement with the modified Rankin Scale (sensitivity 88%, specificity 82%, kappa 0.67). The IDI accurately identified post-stroke medication use (sensitivities 81%–94%, specificities 78%–91%) and thrombectomy interventions (sensitivity 88%, kappa 0.91).

Interpretation

The use of administrative data to ascertain stroke cases, risk factors, interventions and outcomes was feasible and compared well with manual hospital data collection making an administrative data based national stroke register possible, although supplementary data collection for comprehensive care evaluation may be required.

Funding

The study was funded by the NZ Health Research Council (HRC 17/037).
背景:使用基于社区的发病率研究和临床登记来评估卒中治疗和结果是资源密集型的,而且往往是地理上有限的。关联的行政数据成本较低,影响范围更广,但可能不那么准确和完整。本研究将行政数据与基于国家医院的研究数据进行比较,以评估行政数据是否代表一个有效的替代方案。方法我们将新西兰全国范围内的观察性研究区域护理研究的数据与新西兰统计局综合数据基础设施(IDI)的行政数据联系起来并进行比较。敏感性、特异性、阳性预测值和Cohen’s kappa系数用于评估病例识别、危险因素、卒中后结局和适用的干预措施。额外的审计探讨了IDI“真假阳性”的有效性。从2018年5月到7月,1719名中风患者在区域护理中心被捕获,1833名在IDI中被捕获。以REGIONS Care为参考标准,IDI对脑卒中病例识别的敏感性为83%,阳性预测值为77%。有300个假阴性和414个假阳性。对两家医院的审计表明,在IDI中确定但被各区域排除在外的一些病例实际上是中风。对于卒中危险因素,IDI对糖尿病(分别为93%和91%)、房颤(分别为87%和90%)和吸烟(分别为71%和97%)的敏感性和特异性较高,但对高血压(61%)和血脂异常(52%)的特异性较低。衍生的IDI有利结果测量与改进的Rankin量表(敏感性88%,特异性82%,kappa 0.67)吻合良好。IDI准确识别脑卒中后药物使用(敏感性81%-94%,特异性78%-91%)和取栓干预(敏感性88%,kappa 0.91)。使用行政数据来确定卒中病例、危险因素、干预措施和结果是可行的,并且与手工医院数据收集相比较,使得基于行政数据的国家卒中登记成为可能,尽管可能需要补充数据收集以进行综合护理评估。该研究由新西兰健康研究委员会(HRC 17/037)资助。
{"title":"Can administrative data be used for a national register of hospitalised stroke patients? A New Zealand validation study","authors":"Marine Corbin ,&nbsp;Hayley J. Denison ,&nbsp;Jeroen Douwes ,&nbsp;Mina Whyte ,&nbsp;Stephanie G. Thompson ,&nbsp;Matire Harwood ,&nbsp;Alan Davis ,&nbsp;John N. Fink ,&nbsp;P. Alan Barber ,&nbsp;John H. Gommans ,&nbsp;Dominique A. Cadilhac ,&nbsp;William M. Levack ,&nbsp;Harry McNaughton ,&nbsp;Joosup Kim ,&nbsp;Valery L. Feigin ,&nbsp;Anna Ranta","doi":"10.1016/j.lanwpc.2025.101768","DOIUrl":"10.1016/j.lanwpc.2025.101768","url":null,"abstract":"<div><h3>Background</h3><div>Using community-based incidence studies and clinical registries to assess stroke care and outcomes is resource intensive and often geographically limited. Linked administrative data are lower-cost and wider-reaching, but potentially less accurate and complete. This study compared administrative data to national hospital-based study data to assess whether administrative data represents a valid alternative.</div></div><div><h3>Methods</h3><div>We linked and compared data from the REGIONS Care Study, a New Zealand nationwide observational study, with administrative data from Statistics New Zealand’s Integrated Data Infrastructure (IDI). Sensitivity, specificity, positive predictive value, and Cohen’s kappa coefficient were used to assess case identification, risk factors, post-stroke outcomes, and interventions as applicable. Additional audits explored the validity of IDI ‘true false positives.’</div></div><div><h3>Findings</h3><div>From May to July 2018, 1719 patients with stroke were captured in REGIONS Care and 1833 in the IDI. Using REGIONS Care as the reference standard, the sensitivity of the IDI for stroke case identification was 83% and the positive predictive value 77%. There were 300 false-negatives and 414 false positives. The audit of two hospitals showed that some cases identified in IDI but excluded by REGIONS were actual strokes. For stroke risk factors, the IDI showed high sensitivity and specificity for diabetes (93% and 91%, respectively), atrial fibrillation (87% and 90%), and smoking (71% and 97%) but lower specificity for hypertension (61%), and dyslipidaemia (52%). A derived IDI favourable outcome measure showed good agreement with the modified Rankin Scale (sensitivity 88%, specificity 82%, kappa 0.67). The IDI accurately identified post-stroke medication use (sensitivities 81%–94%, specificities 78%–91%) and thrombectomy interventions (sensitivity 88%, kappa 0.91).</div></div><div><h3>Interpretation</h3><div>The use of administrative data to ascertain stroke cases, risk factors, interventions and outcomes was feasible and compared well with manual hospital data collection making an administrative data based national stroke register possible, although supplementary data collection for comprehensive care evaluation may be required.</div></div><div><h3>Funding</h3><div>The study was funded by the <span>NZ Health Research Council</span> (HRC 17/037).</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"66 ","pages":"Article 101768"},"PeriodicalIF":8.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145926781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Lancet Regional Health: Western Pacific
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1